p53 mutational spectra and the role of methylated CpG sequences

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 450, Issue 1-2, 2000, Pages 155-166

  Pfeifer, Gerd P ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Cancer; Methylation; Mutation; p53

Indexed keywords

5 METHYLCYTOSINE; CIGARETTE SMOKE; CYTOSINE; DINUCLEOTIDE; DNA BASE; GUANINE; PROTEIN P53;

CARCINOGENESIS; DNA METHYLATION; DNA SEQUENCE; GENE MUTATION; HUMAN; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SMOKING; SUNLIGHT; ULTRAVIOLET RADIATION;

EID: 0034732883     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(00)00022-1     Document Type: Article

References (98)

1. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878.
2. Hussain S.P., Harris C.C. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res. 58:1998;4023-4037.
3. Hainaut P., Hernandez T., Robinson A., Rodriguez-Tome P., Flores T., Hollstein M., Harris C.C., Montesano R. IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res. 26:1998;205-213.
4. Aguilar F., Hussain S.P., Cerutti P. Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl. Acad. Sci. USA. 90:1993;8586-8590.
5. Tornaletti S., Pfeifer G.P. Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science. 263:1994;1436-1438.
6. Denissenko M.F., Pao A., Tang M.-S., Pfeifer G.P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science. 274:1996;430-432.
7. Denissenko M.F., Chen J.X., Tang M.-S., Pfeifer G.P. Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc. Natl. Acad. Sci. USA. 94:1997;3893-3898.
8. Tommasi S., Denissenko M.F., Pfeifer G.P. Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. Cancer Res. 57:1997;4727-4730.
9. Harris C.C. p53 Tumor suppressor gene: from the basic research laboratory to the clinic- an abridged historical perspective. Carcinogenesis. 17:1996;1187-1198.
10. Hollstein M., Moeckel G., Hergenhahn M., Spiegelhalder B., Keil M., Werle-Schneider G., Bartsch H., Brickmann J. On the origins of tumor mutations in cancer genes: insights from the p53 gene. Mutat. Res. 405:1998;145-154.
11. Rodin S.N., Holmquist G.P., Rodin A.S. CpG transition strand assymetry and hitch-hiking mutations as measures of tumorigenic selection in shaping the p53 mutational spectrum. Int. J. Mol. Med. 1:1998;191-199.
12. Strauss B.S. Silent and multiple mutations in p53 and the question of the hypermutability of tumors. Carcinogenesis. 18:1997;1445-1452.
13. Rideout W.M. III, Coetzee G.A., Olumi A.F., Jones P.A. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science. 249:1990;1288-1290.
14. Magewu A.N., Jones P.A. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol. Cell. Biol. 14:1994;4225-4232.
15. Tornaletti S., Pfeifer G.P. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene. 10:1995;1493-1499.
16. Laird P.W., Jaenisch R. The role of DNA methylation in cancer genetics and epigenetics. Annu. Rev. Genet. 30:1996;441-464.
17. Brash D.E., Rudolph J.A., Simon J.A., Lin A., McKenna G.J., Baden H.P., Halperin A.J., Pontén J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA. 88:1991;10124-10128.
18. Jones P.A. DNA methylation errors and cancer. Cancer Res. 56:1996;2463-2467.
19. Gonzalgo M.L., Jones P.A. Mutagenic and epigenetic effects of DNA methylation. Mutat. Res. 386:1997;107-118.
20. Cha R.S., Thilly W.G., Zarbl H. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations. Proc. Natl. Acad. Sci. USA. 91:1994;3749-3753.
21. Setlow R.B. The wavelengths in sunlight effective in producing skin cancer: a theoretical analysis. Proc. Natl. Acad. Sci. USA. 71:1974;3363-3366.
22. Mortimer P. Squamous cell and basal cell skin carcinoma and rarer histologic types of skin cancer. Curr. Opin. Oncol. 3:1991;349-354.
23. Dumaz N., Drougard C., Sarasin A., Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. USA. 90:1993;10529-10533.
24. Ziegler A., Leffell D.J., Kunala S., Sharma H.W., Gailani M., Simon J.A., Halperin A.J., Baden H.P., Shapiro P.E., Bale A.E., Brash D.E. Mutation hot spots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl. Acad. Sci. USA. 90:1993;4216-4220.
25. Wood R.D., Skopek T.R., Hutchison F. Changes in DNA base sequence induced by targeted mutagenesis of lambda phage by ultraviolet light. J. Mol. Biol. 173:1984;273-291.
26. Miller J.H. Mutagenic specificity of ultraviolet light. J. Mol. Biol. 182:1985;45-68.
27. Sage E., Lamolet B., Brulay E., Moustacchi E., Chteauneuf A., Drobetsky E.A. Mutagenic specificity of solar UV light in nucleotide excision repair-deficient rodent cells. Proc. Natl. Acad. Sci. USA. 93:1996;176-180.
28. Pfeifer G.P. Formation and processing of UV photoproducts: effects of DNA sequence and chromatin environment. Photochem. Photobiol. 65:1997;270-283.
29. Eisenstadt E., Warren A.J., Porter J., Atkins D., Miller J.H. Carcinogenic epoxides of benzo(a)pyrene and cyclopenta(cd)pyrene induce base substitutions via specific transversions. Proc. Natl. Acad. Sci. USA. 79:1982;1945-1949.
30. Chen R.-H., Maher V.M., McCormick J.J. Effect of excision repair by diploid human fibroblasts on the kinds and locations of mutations induced by (+)-7b,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in the coding region of the HPRT gene. Proc. Natl. Acad. Sci. USA. 87:1990;8680-8684.
31. Mazur M., Glickman B. Sequence specificity of mutations induced by benzo(a)pyrene-7,8-diol-9,10-epoxide at endogenous APRT gene in CHO cells. Somat. Cell Mol. Genet. 14:1988;393-400.
32. Ruggeri B., DiRado M., Zhang S.Y., Bauer B., Goodrow T., Klein-Szanto A.J.P. Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc. Natl. Acad. Sci. USA. 90:1993;1013-1017.
33. Hernandez-Boussard T.M., Hainaut P. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database. Environ. Health Perspect. 106:1998;385-391.
34. Bennett W.P., Hussain S.P., Vahakangas K.H., Khan M.A., Sheilds P.G., Harris C.C. Molecular epidemiology of human cancer risk: gene-environment interactions and mutation spectrum in human lung cancer. J. Pathol. 187:1999;8-18.
35. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 350:1991;429-431.
36. Hsu I.C., Metcalf R.A., Sun T., Welsh J.A., Wang N.J., Harris C.C. Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature. 350:1991;427-428.
37. Puisieux A., Lim S., Groopman J., Ozturk M. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res. 51:1991;6185-6189.
38. Yang A.S., Jones P.A., Shibata A. The mutational burden of 5-methylcytosine. Russo V.E.A., Martienssen R., Riggs A.D. Epigenetic Mechanisms of Gene Regulation. 1996;77-94 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
39. Riggs A.D., Jones P.A. 5-Methylcytosine, gene regulation, and cancer. Adv. Cancer Res. 40:1983;1-30.
40. Bird A.P. The essentials of DNA methylation. Cell. 70:1992;5-8.
41. Coulondre C., Miller J.H., Farabaugh P.J., Gilbert W. Molecular basis of base substitution hotspots in Escherichia coli. Nature. 274:1978;775-780.
42. Sommer S.S. Recent human germ-line mutation: inferences from patients with hemophilia B. Trends Genet. 11:1995;141-147.
43. O'Neill J.P., Finette B.A. Transition mutations at CpG dinucleotides are the most frequent in vivo spontaneous single-base substitution mutation in the human HPRT gene. Environ. Mol. Mutagen. 32:1998;188-191.
44. Sved J., Bird A. The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutational model. Proc. Natl. Acad. Sci. USA. 87:1990;4692-4696.
45. Schorderet D.F., Gartler S.M. Analysis of CpG suppression in methylated and nonmethylated species. Proc. Natl. Acad. Sci. USA. 89:1992;957-961.
46. Chen J.X., Zheng Y., West M., Tang M.-S. Carcinogens preferentially bind at methylated CpG in the p53 mutational hotspots. Cancer Res. 58:1998;2070-2075.
47. Pfeifer G.P., Denissenko M.F. Formation and repair of DNA adducts in the p53 gene: relation to cancer mutations? Environ. Mol. Mutagen. 31:1998;197-205.
48. Frederico L.A., Kunkel T.A., Shaw B.R. A sensitive genetic assay for the detection of cytosine deamination: determination of rate constants and the activation energy. Biochemistry. 29:1990;2532-2537.
49. Lindahl T. Instability and decay of the primary structure of DNA. Nature. 362:1993;709-715.
50. Shen J.C., Rideout W.M. III, Jones P.A. The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Res. 22:1994;972-976.
51. Wang R.Y., Kuo K.C., Gehrke C.W., Huang L.H., Ehrlich M. Heat- and alkali-induced deamination of 5-methylcytosine and cytosine residues in DNA. Biochim. Biophys. Acta. 697:1982;371-377.
52. Ehrlich M., Norris K.F., Wang R.Y., Kuo K.C., Gehrke C.W. DNA cytosine methylation and heat-induced deamination. Biosci. Rep. 6:1986;387-393.
53. Ehrlich M., Zhang X.-Y., Inamdar N.M. Spontaneous deamination of cytosine and 5-methylcytosine residues in DNA and replacement of 5-methylcytosine residues with cytosine residues. Mutat. Res. 238:1990;277-286.
54. Cooper D.N., Youssoufian H. The CpG dinucleotide and human genetic disease. Hum. Genet. 78:1988;151-155.
55. Schmutte C., Yang A.S., Beart R.W., Jones P.A. Base excision repair of U:G mismatches at a mutational hotspot in the p53 gene is more efficient than base excision repair of T:G mismatches in extracts of human colon tumors. Cancer Res. 55:1995;3742-3746.
56. Neddermann P., Gallinari P., Lettieri T., Schmid D., Truong O., Hsuan J.J., Wiebauer K., Jiricny J. Cloning and expression of human G/T mismatch-specific thymine-DNA glycosylase. J. Biol. Chem. 271:1996;12767-12774.
57. Saparbaev M., Laval J. 3,N4-ethenocytosine, a highly mutagenic adduct, is a primary substrate for Escherichia coli double-stranded uracil-DNA glycosylase and human mismatch-specific thymine-DNA glycosylase. Proc. Natl. Acad. Sci. USA. 95:1998;8508-8513.
58. Hang B., Medina M., Fraenkel-Conrat H., Singer B. A 55-kDa protein isolated from human cells shows DNA glycosylase activity toward 3,N4-ethenocytosine and the G/T mismatch. Proc. Natl. Acad. Sci. USA. 95:1998;13561-13566.
59. Hendrich B., Hardeland U., Ng H.-H., Jiricny J., Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature. 401:1999;301-304.
60. Yang A.S., Gonzalgo M.L., Zingg J.M., Millar R.P., Buckley J.D., Jones P.A. The rate of CpG mutation in Alu repetitive elements within the p53 tumor suppressor gene in the primate germline. J. Mol. Biol. 258:1996;240-250.
61. Riccio A., Aaltonen L.A., Godwin A.K., Loukola A., Percesepe A., Salovaara R., Masciullo V., Genuardi M., Paravatou-Petsotas M., Bassi D.E., Ruggeri B.A., Klein-Szanto A.J., Testa J.R., Neri G., Bellacosa A. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat. Genet. 23:1999;266-268.
62. Schmutte C., Jones P.A. Involvement of DNA methylation in human carcinogenesis. Biol. Chem. 379:1998;377-388.
63. Marnett L.J., Burcham P.C. Endogenous DNA adducts: potential and paradox. Chem. Res. Toxicol. 6:1993;771-785.
64. Holmquist G.P. Endogenous lesions, S-phase-independent spontaneous mutations, and evolutionary strategies for base excision repair. Mutat. Res. 400:1998;59-68.
65. Wagner J., Hu R.C.C., Ames B.N. Endogenous oxidative damage of deoxycytidine in DNA. Proc. Natl. Acad. Sci. USA. 89:1992;3380-3384.
66. Shen J.C., Rideout W.M., Jones P.A. High frequency mutagenesis by a DNA methyltransferase. Cell. 71:1992;1073-1080.
67. Wyszynski M., Gabbara S., Bhagwat A.S. Cytosine deaminations catalyzed by DNA cytosine methyltransferases are unlikely to be the major cause of mutational hot spots at sites of cytosine methylation in Escherichia coli. Proc. Natl. Acad. Sci. USA. 91:1994;1574-1578.
68. Yang A.S., Shen J.C., Zingg J.M., Mi S., Jones P.A. HhaI and HpaII DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair. Nucleic Acids Res. 23:1995;1380-1387.
69. Schmutte C., Yang A.S., Nguyen T.-D.T., Beart R.W., Jones P.A. Mechanisms for the involvement of DNA methylation in colon carcinogenesis. Cancer Res. 56:1996;2375-2381.
70. Zuo S., Boorstein R.J., Teebor G.W. Oxidative damage to 5-methylcytosine in DNA. Nucleic Acids Res. 25:1995;3239-3243.
71. Denissenko M.F., Koudriakova T.B., Smith L., O'Connor T.R., Riggs A.D., Pfeifer G.P. The P53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Oncogene. 17:1998;3007-3013.
72. Pfeifer G.P., Holmquist G.P. Mutagenesis in the p53 gene. Biochim. Biophys. Acta. 1333:1997;M1-M8.
73. Pfeifer G.P., Drouin R., Riggs A.D., Holmquist G.P. In vivo mapping of a DNA adduct at nucleotide resolution: detection of pyrimidine (6-4) pyrimidone photoproducts by ligation-mediated polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 88:1991;1374-1378.
74. Pfeifer G.P., Drouin R., Riggs A.D., Holmquist G.P. Binding of transcription factors creates hot spots for UV photoproducts in vivo. Mol. Cell. Biol. 12:1992;1798-1804.
75. Pfeifer G.P., Drouin R., Holmquist G.P. Detection of DNA adducts at the DNA sequence level by ligation-mediated PCR. Mutat. Res. 288:1993;39-46.
76. Denissenko M.F., Pao A., Pfeifer G.P., Tang M.-S. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers. Oncogene. 16:1998;1241-1247.
77. You Y.-H., Li C., Pfeifer G.P. Involvement of 5-methylcytosine in sunlight-induced mutagenesis. J. Mol. Biol. 293:1999;493-503.
78. Pfeifer G.P., Tang M.-S., Denissenko M.F. Mutation hotspots and DNA methylation. Curr. Topics Microbiol. Immunol. 2000;. in press.
79. Jiang N., Taylor J.-S. In vivo evidence that UV-induced C-T mutations at dipyrimidine sites could result from the replicative bypass of cis-syn cyclobutane dimers or their deamination products. Biochemistry. 32:1993;472-481.
80. Douki T., Cadet J. Formation of cyclobutane dimers and (6-4) photoproducts upon far-UV photolysis of 5-methylcytosine-containing dinucleoside monophosphates. Biochemistry. 33:1994;11942-11950.
81. Tu Y., Dammann R., Pfeifer G.P. Sequence and time-dependent deamination of cytosine bases in UVB-induced cyclobutane pyrimidine dimers in vivo. J. Mol. Biol. 284:1998;297-311.
82. Dumaz N., van Kranen H.J., de Vries A., Berg R.J., Wester P.W., van Kreijl C.F., Sarasin A., Daya-Grosjean L., de Gruijl F.R. The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice. Carcinogenesis. 18:1997;897-904.
83. van Kranen H.J., de Gruijl F.R., de Vries A., Sontag Y., Wester P.W., Senden H.C., Rozemuller E., vanKreijl C.F. Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless mice. Carcinogenesis. 16:1995;1141-1147.
84. Queille S., Seite S., Tison S., Medaisko C., Drougard C., Fourtanier A., Sarasin A., Daya-Grosjean L. p53 mutations in cutaneous lesions induced in the hairless mouse by a solar ultraviolet light simulator. Mol. Carcinogen. 22:1998;167-174.
85. Ananthaswamy H.N., Fourtanier A., Evans R.L., Tison S., Medaisko C., Ullrich S.E., Kripke M.L. p53 Mutations in hairless SKH-hr1 mouse skin tumors induced by a solar simulator. Photochem. Photobiol. 67:1998;227-232.
86. Loeb L.A., Ernster V.L., Warner K.E., Abbotts J., Laszlo J. Smoking and lung cancer: an overview. Cancer Res. 44:1984;5940-5958.
87. Hecht S.S., Carmella S.G., Murphy S.E., Foiles P.G., Chung F.L. Carcinogen biomarkers related to smoking and upper aerodigestive tract cancer. J. Cell. Biochem. Suppl. 17F:1993;27-35.
88. Smith L.E., Denissenko M.F., Bennett W.P., Amin S., Tang M.-S., Pfeifer G.P. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J. Natl. Cancer Inst. 2000;. revised manuscript submitted.
89. Van Duuren B.L. The polynuclear aromatic hydrocarbons in cigarette smoke condensate II. J. Natl. Cancer Inst. 21:1958;623-630.
90. Wynder E.L., Hoffmann D. A study of tobacco carcinogenesis: VII. The role of higher polycyclic hydrocarbons. Cancer. 12:1959;1079-1086.
91. Alexandrov K., Rojas M., Geneste O., Castegnaro M., Camus A.M., Petruzzelli S., Giuntini C., Bartsch H. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res. 52:1992;6248-6253.
92. Weisenberger D.J., Romano L.J. Cytosine methylation in a CpG sequence leads to enhanced reactivity with benzo[a]pyrene diol epoxide that correlates with a conformational change. J. Biol. Chem. 274:1999;23948-23955.
93. Skopek T.R., Kort K.L., Marino D.R., Mittal L.V., Umbenhauer D.R., Laws G.M., Adams S.P. Mutagenic response of the endogenous hprt gene and lacl transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice. Environ. Mol. Mutagen. 28:1996;376-384.
94. You Y.-H., Halangoda A., Buettner V., Hill K., Sommer S., Pfeifer G.P. Methylation of CpG dinucleotides in the lacl gene of the Big Blue® transgenic mouse. Mutat. Res. 420:1998;55-65.
95. Mellon I., Spivak G., Hanawalt P.C. Selective removal of transcription blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell. 51:1987;241-249.
96. Chen R.H., Maher V.M., Brouwer J., van de Putte P., McCormick J.J. Preferential repair and strand-specific repair of benzo(a)pyrene diol epoxide adducts in the HPRT gene of diploid human fibroblasts. Proc. Natl. Acad. Sci. USA. 89:1992;5413-5417.
97. 6-methylguanine-DNA methyltransferase by 5-methylcytosine. Cancer Res. 54:1994;327-329.
98. Provost G.S., Kretz P.L., Hamner R.T., Matthews C.D., Rogers B.J., Lundberg K.S., Dycaico M.J., Short J.M. Transgenic systems for in vivo mutation analysis. Mutat. Res. 288:1993;133-149.